Rx
Birlacal D 500MG Tab
RISEMARKER PHARMACEUTICALS - tablet - 500 mg - 10 S
Standard delivery
₹52
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated June 2026
Medicines with the same active ingredient and strength as Sitanoon-D 100/10MG Tab.
You are viewing
Sitanoon-D 100/10MG Tab
tablet - 10 S
₹159
₹15.94 per tablet
UNISON PHARMACEUTICALS · tablet - 100 mg - 10 S · Rx
₹67
₹6.68 per tablet
SYSTOPIC LAB · tablet - 10 S · Rx
₹117
₹11.72 per tablet
Sitagliptin 100 mg + Dapagliflozin 10 mg
Type 2 diabetes mellitus (as an adjunct to diet and exercise) to improve glycaemic control when dual therapy with a DPP-4 inhibitor and an SGLT2 inhibitor is appropriate.
Sitagliptin (DPP-4 inhibitor) increases incretin levels, leading to glucose-dependent increase in insulin release and reduced glucagon secretion. Dapagliflozin (SGLT2 inhibitor) reduces glucose reabsorption in the kidneys, increasing urinary glucose excretion and lowering blood sugar.
Take orally exactly as prescribed by the doctor, usually once daily, with or without food. Swallow whole with water; take at the same time each day. Maintain adequate hydration; do not stop or change dose without medical advice.
Common side effects of Sitanoon-D 100/10MG Tab may include:
RISEMARKER PHARMACEUTICALS - tablet - 500 mg - 10 S
Standard delivery
RISEMARKER PHARMACEUTICALS - tablet - 10 S
Standard delivery
RISEMARKER PHARMACEUTICALS - tablet - 3.125 mg - 10 S
Standard delivery
RISEMARKER PHARMACEUTICALS - tablet - 6.25 mg - 10 S
Standard delivery
RISEMARKER PHARMACEUTICALS - tablet - 10 S
Standard delivery
RISEMARKER PHARMACEUTICALS - tablet - 10 S
Standard delivery
RISEMARKER PHARMACEUTICALS - tablet - 10 mg - 10 S
Standard delivery
RISEMARKER PHARMACEUTICALS - injection - 2 ml
Standard delivery
IPCA LABORATORIES LTD` · tablet - 100 mg - 10 S · Rx
₹130
₹12.99 per tablet
A substitute contains the same active ingredient (salt), in the same strength, as Sitanoon-D 100/10MG Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.
For type 2 diabetes only (not for type 1 diabetes). Risk of diabetic ketoacidosis (may occur even with near-normal glucose) with SGLT2 inhibitors—seek urgent care for nausea, vomiting, abdominal pain, rapid breathing. May cause dehydration/low blood pressure; use caution in elderly and with diuretics. Monitor kidney function; not recommended in severe renal impairment or dialysis (dapagliflozin effectiveness reduced and risk increases). Increased risk of genital/urinary infections; maintain hygiene and report symptoms. Temporarily stop before major surgery or during acute illness/fasting as advised. Use caution in history of pancreatitis (sitagliptin) and severe hypersensitivity reactions.